Skip to content

Functional Inspiratory Muscle Training in Chronic Kidney Disease

The Effects of Functional Inspiratory Muscle Training on Respiratory and Peripheral Muscle Functions in Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04958759
Enrollment
38
Registered
2021-07-12
Start date
2021-03-01
Completion date
2023-05-03
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Keywords

Respiratory muscle

Brief summary

Effects of functional inspiratory muscle training by telerehabilitation on respiratory and peripheral functions, functional capacity, diaphragm thickness and mobility, posture, quality of life, cognitive function, fatigue, physical activity, endothelial function and aortic stiffness in patients with chronic kidney disease will be investigated.

Interventions

The inspiratory muscle training program will be consist of 4 weeks of foundation inspiratory muscle training and 6 weeks of functional inspiratory muscle training

OTHERInspiratory Muscle Training

The inspiratory muscle training program will be consist of 10 weeks of foundation inspiratory muscle training

OTHERBreathing exercises

The program will be consist of 10 weeks of breathing exercises

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients with chronic kidney disease not receiving dialysis * Access to the online program * Volunteering to participate in the research

Exclusion criteria

* Having a musculoskeletal problem * Having decompensated diabetes * Having uncontrolled hypertension

Design outcomes

Primary

MeasureTime frameDescription
Respiratory muscle strength10 minutesRespiratory muscle strength will be evaluated using mouth pressure device
Respiratory muscle endurance10 minutesRespiratory muscle endurance will be evaluated using incremental load test
Pulmonary function5 minutesPulmonary functions will be evaluated using spirometry
Peripheral muscle strength5 minutesPeripheral muscle strength will be evaluated using dynamometer
Endurance of trunk muscles10 minutesEndurance of trunk muscles will be evaluated using plank, side plank, flexor endurance and pelvic bridge test
Lower extremity muscle endurance1 minutesLower extremity muscle endurance will be evaluated using sit-to-stand test
Functional capacity10 minutesFunctional capacity will be evaluated using six-minute walk test
Diaphragm thickness and mobility20 minutesDiaphragm thickness and mobility will be evaluated using ultrasonography

Secondary

MeasureTime frameDescription
Physical activity5 minutesPhysical activity level will be evaluated using International Physical Activity Questionnaire-Short Form
Aortic stiffness10 minutesAortic stiffness will be evaluated using transthoracic echocardiography. Aortic diameters can be measured by M-mode tracing of the level of 3-4 cms above the aortic valve during diastole and systole
Fatigue5 minutesFatigue will be evaluated using Multidimensional Assessment of Fatigue scale
Balance5 minutesBalance will be evaluated using timed up and go test
Static balance5 minutesBalance will be evaluated using one-legged standing test
Posture5 minutesPosture will be evaluated using Corbin Postural Assessment scale. Lateral and posterior views will be assessed (0 = absent, 1 = mild, 2 = moderate, 3 = severe) and posture score will be determined as excellent (0-2), very good (3-4), good (5-7), fair (8-11) and poor (\>12).
Qol10 minutesQuality of life will be evaluated using Nottingham Health Profile
Cognitive function5 minutesCognitive function will be evaluated using Standardised Mini-Mental State Examination
Endothelial function10 minutesEndothelial function will be evaluated using echocardiography. After a resting baseline Brachial artery diameter will be recorded, the cuff used in blood pressure measurement will be inflated 25-50 mmHg above the systolic blood pressure value and maintaining that pressure for 5 min. The brachial artery diameter will be measured again after the cuff is deflated.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026